Home › Funds › MUFG Securities EMEA plc › ELV
MUFG Securities EMEA plc position in ELV
ELEVANCE HEALTH INC FORMERLY · Health Care
MUFG Securities EMEA plc reported holding 110,952 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$43.1M, representing 0.47% of its reported portfolio and ranking #48 among its reported holdings. MUFG Securities EMEA plc has disclosed ELV holdings in 8 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How MUFG Securities EMEA plc's ELV position evolved
MUFG Securities EMEA plc first disclosed a stake in ELV in Q4 2023 at 30,000 shares (US$14.1M). The position peaked in Q3 2026 at 110,952 shares, worth US$43.1M. Across 8 filings, MUFG Securities EMEA plc increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 110,952 shares valued at US$43.1M — an increase of 102,452 shares quarter over quarter.. Notable position changes include a 1743% increase in Q3 2025 (shares rose 9% over the following quarter), a 87% increase in Q1 2026 (shares rose 33% over the following quarter), a 1205% increase in Q3 2026 (shares rose 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 30.00K | $14.15M | New |
| Q4 2024 | 27.00K | $9.96M | New |
| Q2 2025 | 668 | $259.82K | New |
| Q3 2025 | 12.31K | $3.98M | Add |
| Q4 2025 | 9.11K | $3.19M | Reduce |
| Q1 2026 | 17.05K | $4.99M | Add |
| Q2 2026 | 8.50K | $3.29M | Reduce |
| Q3 2026 | 110.95K | $43.14M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ELV and 13F data
ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ELV
- Wellington Management Group 9.21M sh · $3.56B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 9.21M sh · $3.56B · Q2 2026
- Sanders Capital, LLC 5.83M sh · $2.27B · Q3 2026
- Harris Associates (Oakmark) 4.92M sh · $1.90B · Q2 2026
- HARRIS ASSOCIATES L P 4.92M sh · $1.90B · Q2 2026
- First Eagle Investment Management 4.20M sh · $1.63B · Q3 2026
- Artisan Partners Limited Partnership 3.76M sh · $1.46B · Q3 2026
More on MUFG Securities EMEA plc
FAQ
How long has MUFG Securities EMEA plc held ELV?
MUFG Securities EMEA plc has disclosed ELV holdings in 8 of the last 12 reported quarters, going back to Q4 2023.
What is MUFG Securities EMEA plc's current position in ELV?
As of Q3 2026, MUFG Securities EMEA plc holds 110.95K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $43.14M, representing 0.47% of its reported portfolio and ranking #48.
Has MUFG Securities EMEA plc been buying or selling ELV?
In the latest 13F filing (Q3 2026), MUFG Securities EMEA plc increased its position in ELV. The position peaked in Q3 2026 at 110.95K shares.
Which other funds hold ELV?
Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.